Scientific Reports (Apr 2022)

Predictive factors for false negatives following sentinel lymph node biopsy in early oral cavity cancer

  • Kouki Miura,
  • Daisuke Kawakita,
  • Isao Oze,
  • Motoyuki Suzuki,
  • Masashi Sugasawa,
  • Kazuhira Endo,
  • Tomohiro Sakashita,
  • Shinichi Ohba,
  • Mikio Suzuki,
  • Akihiro Shiotani,
  • Naoyuki Kohno,
  • Takashi Maruo,
  • Chiaki Suzuki,
  • Takehiro Iki,
  • Nao Hiwatashi,
  • Fumihiko Matsumoto,
  • Kenya Kobayashi,
  • Minoru Toyoda,
  • Kenji Hanyu,
  • Yusuke Koide,
  • Yoshiko Murakami,
  • Yasuhisa Hasegawa

DOI
https://doi.org/10.1038/s41598-022-10594-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Prophylactic elective neck dissection (ND) with navigation surgery using radioisotope-based sentinel lymph node biopsy (SLNB) is non-inferior to elective ND in terms of survival but has an advantage in postoperative functional disability. We conducted a subgroup analysis to identify predictive factors for false-negative (FN)-SLNB in patients with early oral cavity cancer. This study is a supplementary analysis using the dataset of a previously reported randomized clinical trial on SLN navigation surgery for oral cancers. This study investigated the association of clinical and SLN-related factors with false-negative cases in the SLNB group. From 2011 to 2016, 275 patients were enrolled and randomly assigned to the ND and SLNB study groups, with 134 patients assigned to the SLNB group. In the SLNB group, seven cases with negative SLNs and neck recurrences were judged as FN-SLNBs according to the general definition. The number of detected SLNs with and without adjusting for the propensity score was significantly associated with FNs in the logistic analysis. FN-SLNB was associated with the number of identified SLNs, suggesting the need for careful postoperative monitoring for neck recurrence in patients with one or two identified SLNs after acquiring sufficient experience in the identification technique.